The variability in treatment response is a major challenge in cancer therapy. Factors such as genetic differences, tumor microenvironment, and drug resistance contribute to this variability. Personalized medicine aims to tailor treatments based on individual genetic profiles, but our understanding of how to effectively apply this in clinical practice is still developing.
